Auditoria em Oncologia - Unimed do Brasil
Auditoria em Oncologia - Unimed do Brasil
Auditoria em Oncologia - Unimed do Brasil
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
• Câncer de estômago metastático• Trastuzumab > sobrevida <strong>em</strong> Her2+• +cisplatin e FU• OS 13,8 meses x 11,1 meses• Van Cuts<strong>em</strong> E et al Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard ch<strong>em</strong>otherapy(CT) in first-line human epidermal growth factor receptor 2 (HER2)- positive advanced gastric cancer (GC). J Clin Oncol27:18s, 2009 (suppl; abstr LBA4509)